Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-3155
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging ; volume:20 ; number:1 ; day:10 ; month:6 ; year:2022 ; pages:1-14 ; date:12.2022
Journal of nanobiotechnology ; 20, Heft 1 (10.6.2022), 1-14, 12.2022
- Urheber
-
Jugniot, Natacha
Massoud, Tarik F.
Dahl, Jeremy J.
Paulmurugan, Ramasamy
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12951-022-01484-9
- URN
-
urn:nbn:de:101:1-2022080619022550214665
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jugniot, Natacha
- Massoud, Tarik F.
- Dahl, Jeremy J.
- Paulmurugan, Ramasamy
- SpringerLink (Online service)
Ähnliche Objekte (12)
Recent advances in targeted strategies for triple-negative breast cancer
Targeted therapies for the treatment of triple-negative breast cancer
Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer
Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Hyaluronic acid-functionalized supramolecular nanophotosensitizers for targeted photoimmunotherapy of triple-negative breast cancer
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Recent advances in targeted strategies for triple-negative breast cancer
Targeted therapies for the treatment of triple-negative breast cancer
Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer
Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Hyaluronic acid-functionalized supramolecular nanophotosensitizers for targeted photoimmunotherapy of triple-negative breast cancer
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Recent advances in targeted strategies for triple-negative breast cancer
Targeted therapies for the treatment of triple-negative breast cancer
Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer
Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Hyaluronic acid-functionalized supramolecular nanophotosensitizers for targeted photoimmunotherapy of triple-negative breast cancer
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
Characterizing triple-negative breast cancer tumors